# Cardiff Lexington Corp (CDIX) > Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/cardiff-lexington-corp/ JSON: https://steadybase.io/company/cardiff-lexington-corp.json Checked Nov 10, 2026. Latest filing read: Aug 12, 2026. ## Company - Legal name: Cardiff Lexington Corp - Ticker: CDIX (OTC) - SEC CIK: 0000811222 - Industry: Services-Offices & Clinics of Doctors of Medicine (SIC 8011) - Headquarters: Lexington, KY - Fiscal year ends: December 31 - SEC filer category: Non-accelerated filer
Smaller reporting company - Website: cardifflexington.com - Investor relations: https://cardifflexington.com/investors/ - LinkedIn: https://www.linkedin.com/company/cardifflexington - Next earnings date: Nov 12, 2026 (estimated from past 8-K timing) ## Key facts - Revenue: $11.5M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 10, 2026). Source: https://www.sec.gov/Archives/edgar/data/811222/000168316826001639/0001683168-26-001639-index.html - Operating income: $1.1M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 10, 2026). Source: https://www.sec.gov/Archives/edgar/data/811222/000168316826001639/0001683168-26-001639-index.html - Net income: -$5.5M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 10, 2026). Source: https://www.sec.gov/Archives/edgar/data/811222/000168316826001639/0001683168-26-001639-index.html - SG&A: $5.3M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 10, 2026). Source: https://www.sec.gov/Archives/edgar/data/811222/000168316826001639/0001683168-26-001639-index.html - Employees: 18 as of Dec 31, 2025, as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/811222/000168316826001639/cardiff_i10k-123125.htm - Shares outstanding: 15,637,361 as of Aug 10, 2026 (10-Q filed Aug 12, 2026). Source: https://www.sec.gov/Archives/edgar/data/811222/000168316826006232/0001683168-26-006232-index.html - Auditor: Gbq Partners, LLC, Columbus, Ohio, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/811222/000168316826001639/cardiff_i10k-123125.htm ## Business Our company is a targeted healthcare holding company dedicated to acquiring and building middle-market niche healthcare clinics, primarily in orthopedics, spine care, and pain management. Source: Item 1. Business, https://www.sec.gov/Archives/edgar/data/811222/000168316826001639/cardiff_i10k-123125.htm ## Annual results | Fiscal year ended | Revenue | Operating income | Net income | SG&A | |---|---|---|---|---| | Dec 31, 2025 | $11.5M | $1.1M | -$5.5M | $5.3M | | Dec 31, 2024 | $8.3M | -$193,504 | -$3.3M | $4.1M | | Dec 31, 2023 | $11.9M | $5.2M | $3.0M | $3.1M | | Dec 31, 2022 | $10.7M | $3.9M | -$5.4M | $2.7M | | Dec 31, 2021 | $9.9M | $1.7M | $666,293 | $4.4M | Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/cardiff-lexington-corp.json ## Officers and directors - Alex H. Cunningham, Chief Executive Officer. LinkedIn: https://linkedin.com/in/alexhcunningham. Source: Form 4 filed Feb 2, 2026, https://www.sec.gov/Archives/edgar/data/811222/000168316826000671/0001683168-26-000671-index.htm - Matthew T. Shafer, Chief Financial Officer. Source: Form 4 filed Jan 16, 2026, https://www.sec.gov/Archives/edgar/data/811222/000168316826000354/0001683168-26-000354-index.htm - Daniel Thompson, Chairman of the Board. Source: Form 4 filed Dec 15, 2025, https://www.sec.gov/Archives/edgar/data/811222/000168316825009171/0001683168-25-009171-index.htm ## Recent 8-K events - Sep 24, 2026: Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/811222/000168316826007348/cardiff_8k.htm - Sep 4, 2026: Item 3.03, Material modification to rights of security holders; Item 5.03, Amendments to articles or bylaws; change in fiscal year; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/811222/000168316826006974/cardiff_8k.htm - Jun 11, 2026: Item 1.01, Entry into a material definitive agreement; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/811222/000168316826004756/cardiff_8k.htm - Feb 3, 2026: Item 3.03, Material modification to rights of security holders; Item 5.03, Amendments to articles or bylaws; change in fiscal year; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/811222/000168316826000709/cardiff_8k.htm - Jan 5, 2026: Item 5.02, Departure or appointment of directors or officers; compensation. Source: https://www.sec.gov/Archives/edgar/data/811222/000168316826000083/cardiff_8k.htm - Aug 14, 2025: Item 4.02, Non-reliance on previously issued financial statements. Source: https://www.sec.gov/Archives/edgar/data/811222/000168316825006130/cardiff_8k.htm - Dec 4, 2024: Item 3.03, Material modification to rights of security holders; Item 5.03, Amendments to articles or bylaws; change in fiscal year; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/811222/000168316824008511/cardiff_8k.htm - Oct 17, 2024: Item 4.02, Non-reliance on previously issued financial statements. Source: https://www.sec.gov/Archives/edgar/data/811222/000168316824007190/cardiff_8k.htm - Sep 19, 2024: Item 4.01, Changes in registrant's certifying accountant; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/811222/000168316824006536/cardiff_8k.htm - Jun 11, 2024: Item 1.01, Entry into a material definitive agreement; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/811222/000168316824004119/cardiff_8k.htm ## Latest filings - 8-K filed Sep 24, 2026: https://www.sec.gov/Archives/edgar/data/811222/000168316826007348/cardiff_8k.htm - 10-K filed Mar 10, 2026: https://www.sec.gov/Archives/edgar/data/811222/000168316826001639/cardiff_i10k-123125.htm - 10-Q filed Aug 12, 2026: https://www.sec.gov/Archives/edgar/data/811222/000168316826006232/cardiff_i10q-063026.htm - DEF 14A filed Feb 27, 2015: https://www.sec.gov/Archives/edgar/data/811222/000101968715000751/cardiff_def14a.htm ## About this data SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from. Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/